Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2-Reference-Cited by-同舟云学术

Induction of influenza type A virus-specific resistance by immunization of mice with a synthetic multiple antigenic peptide vaccine that contains ectodomains of matrix protein 2

Published:2003-06 Issue:19-20 Volume:21 Page:2616-2626
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Mozdzanowska Krystyna,Feng JinQi,Eid Mark,Kragol Goran,Cudic Mare,Otvos Laszlo,Gerhard Walter

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference49 articles.

1. Protection of mice against influenza A virus challenge by vaccination with baculovirus-expressed M2 protein;Slepushkin;Vaccine,1995

2. Modified M2 proteins produce heterotypic immunity against influenza A virus;Frace;Vaccine,1999

3. A universal influenza A vaccine based on the extracellular domain of the M2 protein;Neirynck;Nat. Med.,1999

4. Protective immunity against influenza A virus induced by immunization with DNA plasmid containing influenza M gene;Okuda;Vaccine,2001

5. Sequences of mRNAs derived from genome RNA segment 7 of influenza virus: colinear and interrupted mRNAs code for overlapping proteins;Lamb;Proc. Natl. Acad. Sci. U.S.A.,1981

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Innate and adaptive immune responses against Influenza A Virus: Immune evasion and vaccination strategies;Immunobiology;2022-11

2. Dendritic cell activation by a micro particulate based system containing the influenza matrix-2 protein virus-like particle (M2e VLP);International Journal of Pharmaceutics;2022-06

3. Mutation in Hemagglutinin Antigenic Sites in Influenza A pH1N1 Viruses from 2015–2019 in the United States Mountain West, Europe, and the Northern Hemisphere;Genes;2022-05-19

4. Recent Advances in the Development of Toll-like Receptor Agonist-Based Vaccine Adjuvants for Infectious Diseases;Pharmaceutics;2022-02-16

5. Universal influenza vaccine technologies and recombinant virosome production;Methods in Microbiology;2022